ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography
Status:
RECRUITING
Trial end date:
2035-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of the ASA-3C trial is to evaluate the role of aspirin and high-intensity statin therapy, respectively, in individuals with severe coronary calcification (coronary calcium score 400) to prevent atherosclerotic cardiovascular disease (ASCVD) events with severe coronary calcification (CAC 400).